- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01309529
Day Zero Urinary Catheter Removal in Gen Thoracic Surgery Patients
Day Zero Urinary Catheter Removal in General Thoracic Surgery Patients Receiving Thoracic Epidural Analgesia: Recatheterization Rates and Urinary Tract Infection Occurrences
Study Overview
Status
Detailed Description
Study Design A prospective study design will be utilized as data will be collected in a prospective manner and standard of care/current practice will be unaltered in the patient population.
Sampling will include all patients that meet the eligibility criteria from March 01, 2011 until August 01, 2011 with a goal of forty-five patients.
Data Collection Protocol
- The patient will be interviewed and given information regarding participation in the study by Principal Investigator and/or research team prior to surgery. Informed Consent Forms will be collected by Principal Investigator and/or research team. Principal Investigator and/or research team will collect all data on Data Collection Sheet.
Thoracic epidural will be placed by the anesthesiologist in pre-op per standard protocol.
- Location of epidural will be documented by Principal Investigator and/or research team on Data Collection Sheet. (See Appendix 1)
- Prior to surgery, if indicated, an indwelling urinary bladder catheter will be placed per pre-operative protocol.
- Post-operative documentation of time, type and settings for epidural infusion will be documented on Data Collection Sheet.
Post-op eligible patients admitted to cardiothoracic step-down unit will be placed on the following protocol:
Thoracic Epidural will be managed by the anesthesia group.
- Any change in prescription or dosing will be documented on the Data Collection Sheet.
If urinary catheter present, will be discontinued at midnight day of surgery, Day Zero; the time of discontinuation will be noted on the Data Collection Sheet.
- If micturition occurs, amount and time will be documented on Data Collection Sheet.
- If no spontaneous void by 0800 post-operative day (POD) 1, bladder scanning will be initiated.
- If ≥ 400 cc per bladder scanner, the thoracic surgeon, surgeon's nurse or the Principal Investigator will not notified.
Any ordered interventions, the response and re- evaluation will be noted on Data Collection Sheet.
- Urinary retention will be defined as > 400 cc and recatheterization (either intermittent or indwelling) will occur.
- Data will only be collected during current surgery hospitalization.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Tiffany E Potter, BSN
- Phone Number: 4223-495-7848
- Email: tiffany_potter@memorial.org
Study Contact Backup
- Name: Laurel Rhyne, ACNP-BC
- Phone Number: 423-495-7834
- Email: laurel_rhyne@memorial.org
Study Locations
-
-
Tennessee
-
Chattanooga, Tennessee, United States, 37404
- Recruiting
- Memorial Hospital
-
Contact:
- Potter
- Email: tiffany_potter@memorial.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- All general thoracic surgery patients with a thoracic epidural catheter.
Exclusion Criteria:
- Men > 65 years old
- History of urologic procedure
- Known benign prostatic hyperplasia
- Admission to intensive care units
- History of urinary retention
- Foreign speaking patient
- Pregnant women and those less than 18 years old
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
thoracic surg, epidural, urine retention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluate rates of recatheterization due to urinary retention and occurrence of urinary tract infections in a general thoracic surgery population receiving thoracic epidural analgesia.
Time Frame: 5 months
|
The current standard of care at study institution is to remove urinary catheter on post operative day zero lowering urinary tract infection and recatheterization rates.
|
5 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Laurel Rhyne, ACNP-BC, Memorial Hospital-Thoracic Program
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB11.03.01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Urinary Tract Infection
-
The Christ HospitalUnknownLower Urinary Tract Symptoms | Postoperative Urinary Tract InfectionUnited States
-
Hospital General Universitario ElcheCompletedSurgical Site Infection
-
Andrew GlennieUnknownSurgical Site Infection
-
Odense University HospitalHvidovre University Hospital; University of Southern Denmark; Region of Southern... and other collaboratorsWithdrawnPostoperative InfectionDenmark
-
University of BirminghamUnknown
-
Brigham and Women's HospitalWithdrawnSurgical Site InfectionUnited States
-
Assiut UniversityRecruitingCesarean Section ComplicationsEgypt
-
Kaiser PermanenteUniversity of California, San DiegoCompletedPelvic Organ Prolapse | Stress Urinary Incontinence | Postoperative Urinary Tract InfectionUnited States
-
Saint Vincent's Hospital, KoreaCompletedSurgical Wound InfectionKorea, Republic of
-
Leiden University Medical CenterMerck Sharp & Dohme LLCCompletedPneumonia | Postoperative Complications | Postoperative Wound InfectionNetherlands